DK0580648T3 - Fremgangsmåde til konditionering af vandopløselige stoffer - Google Patents

Fremgangsmåde til konditionering af vandopløselige stoffer

Info

Publication number
DK0580648T3
DK0580648T3 DK92907877.2T DK92907877T DK0580648T3 DK 0580648 T3 DK0580648 T3 DK 0580648T3 DK 92907877 T DK92907877 T DK 92907877T DK 0580648 T3 DK0580648 T3 DK 0580648T3
Authority
DK
Denmark
Prior art keywords
soluble substances
conditioning water
vacuum
water
micronised
Prior art date
Application number
DK92907877.2T
Other languages
Danish (da)
English (en)
Inventor
Edib Jakupovic
Jan Trofast
Eva Trofast
Katarina Bystroem
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0580648(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0580648T3 publication Critical patent/DK0580648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treating Waste Gases (AREA)
  • Cosmetics (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
DK92907877.2T 1991-04-11 1992-03-24 Fremgangsmåde til konditionering af vandopløselige stoffer DK0580648T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
DK0580648T3 true DK0580648T3 (da) 1996-09-16

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92907877.2T DK0580648T3 (da) 1991-04-11 1992-03-24 Fremgangsmåde til konditionering af vandopløselige stoffer
DK95111178T DK0680752T3 (da) 1991-04-11 1992-03-24 Konditionerede vandopløselige stoffer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95111178T DK0680752T3 (da) 1991-04-11 1992-03-24 Konditionerede vandopløselige stoffer

Country Status (28)

Country Link
US (1) US5562923A (enExample)
EP (3) EP0680752B1 (enExample)
JP (2) JP3400999B2 (enExample)
KR (1) KR100216384B1 (enExample)
AT (2) ATE208613T1 (enExample)
AU (1) AU662519B2 (enExample)
BG (1) BG61474B1 (enExample)
CA (1) CA2106975C (enExample)
CZ (1) CZ286936B6 (enExample)
DE (2) DE69232207T2 (enExample)
DK (2) DK0580648T3 (enExample)
EE (1) EE02970B1 (enExample)
ES (2) ES2168322T3 (enExample)
FI (1) FI105388B (enExample)
GR (1) GR3020602T3 (enExample)
HK (1) HK52497A (enExample)
HU (1) HU211116B (enExample)
IE (1) IE921144A1 (enExample)
IS (1) IS3834A (enExample)
NO (1) NO311867B1 (enExample)
PL (1) PL168232B1 (enExample)
PT (1) PT680752E (enExample)
RO (1) RO115779B1 (enExample)
RU (1) RU2112507C1 (enExample)
SE (1) SE9101090D0 (enExample)
SG (1) SG43180A1 (enExample)
SK (1) SK280310B6 (enExample)
WO (1) WO1992018110A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
CA2213700C (en) 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
ATE284677T1 (de) * 1997-03-20 2005-01-15 Schering Corp Herstellung von pulveragglomeraten
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DE69814428T2 (de) * 1997-09-29 2004-05-13 Nektar Therapeutics, San Carlos In verneblern verwendbare, stabilisierte zubereitungen
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
WO2004087102A2 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
PL1844765T3 (pl) 2003-06-13 2015-06-30 Skendi Finance Ltd Formulacja estradiol-progesteron o spowolnionym uwalnianiu
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
AU2004281270B2 (en) * 2003-10-17 2010-05-06 E.I. Dupont De Nemours And Company Adhesion of foil to thermoplastic polymers
BRPI0506610A (pt) 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
PT2234595E (pt) * 2007-12-13 2013-01-24 Novartis Ag Processo para redução da tendência de um sal de glicopirrónio para se agregar durante a armazenagem
RU2376079C1 (ru) * 2008-06-11 2009-12-20 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет инженерной экологии" Способ получения порошков микронизированных частиц
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
US20110224229A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Novel Crystalline Form
RU2013153466A (ru) 2011-06-29 2015-08-10 Астразенека Аб Кристаллическая форма производных индазолиламида для лечения опосредованных глюкокортикоидными рецепторами расстройств
SG11201507286QA (en) * 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
EP0680752B1 (en) 2001-11-14
US5562923A (en) 1996-10-08
EP0580648A1 (en) 1994-02-02
FI934429A0 (fi) 1993-10-08
BG98147A (bg) 1994-12-02
CZ211693A3 (en) 1994-04-13
SK108893A3 (en) 1994-03-09
DE69210601T2 (de) 1996-10-02
CA2106975A1 (en) 1992-10-12
DK0680752T3 (da) 2002-02-25
HU9302870D0 (en) 1993-12-28
SE9101090D0 (sv) 1991-04-11
AU662519B2 (en) 1995-09-07
GR3020602T3 (en) 1996-10-31
HK52497A (en) 1997-05-02
DE69232207T2 (de) 2002-08-01
DE69232207D1 (de) 2001-12-20
CZ286936B6 (cs) 2000-08-16
EP0508969A1 (en) 1992-10-14
JP3400999B2 (ja) 2003-04-28
PT680752E (pt) 2002-05-31
PL168232B1 (pl) 1996-01-31
RU2112507C1 (ru) 1998-06-10
NO933575L (no) 1993-10-06
FI105388B (fi) 2000-08-15
EP0680752A2 (en) 1995-11-08
AU1534792A (en) 1992-11-17
CA2106975C (en) 2002-03-19
ATE208613T1 (de) 2001-11-15
EE02970B1 (et) 1997-04-15
EP0680752A3 (enExample) 1995-11-22
ATE137671T1 (de) 1996-05-15
WO1992018110A1 (en) 1992-10-29
IS3834A (is) 1992-10-12
IE921144A1 (en) 1992-10-21
FI934429L (fi) 1993-10-08
DE69210601D1 (de) 1996-06-13
SK280310B6 (sk) 1999-11-08
ES2168322T3 (es) 2002-06-16
BG61474B1 (en) 1997-09-30
KR100216384B1 (ko) 1999-08-16
RO115779B1 (ro) 2000-06-30
HU211116B (en) 1995-10-30
ES2086733T3 (es) 1996-07-01
HUT65095A (en) 1994-04-28
NO933575D0 (no) 1993-10-06
JPH06506454A (ja) 1994-07-21
NO311867B1 (no) 2002-02-11
JP2003155228A (ja) 2003-05-27
EP0580648B1 (en) 1996-05-08
SG43180A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
DK0580648T3 (da) Fremgangsmåde til konditionering af vandopløselige stoffer
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
FI960265A7 (fi) Osmoottisia välineitä, joissa on höyryä läpäiseviä päällysteitä
DE69106828D1 (de) Antimykotische Zusammensetzung in Trocken Aerosol Form.
MY100201A (en) Water-dilutable wood-preserving liquids
FR2639607B1 (fr) Procede de stabilisation en altitude d'un ballon stratospherique et ballon adapte a sa mise en oeuvre
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
ES2076330T3 (es) Pelicula para uso agricola.
IL90242A0 (en) A process for drying water-wet polycarbonate membranes
NO162250C (no) Poroest diafragma for elektrolyseceller og fremgangsmaate til fremstilling av diafragmaet.
JPS51142488A (en) Novel photocromic material
JPS5281078A (en) Permeable membrane module
JPS5232042A (en) Method to prevent polyethylene cross-linked with organosilane from deg radation
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
Momen Development of an experimental set up for preservation of food grains using controlled atmosphere storage
NL7812663A (en) Polymeric filtration membranes - cast from solns. in water-immiscible solvents and immersed in alcohol bath, can be stored in the dry state
JPS51122611A (en) Material for storing hydrogen
JPS5348989A (en) Artificial kidney
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS51131552A (en) A coating method
JPS51117969A (en) Curing apparatus using electron beam irradiation
JPS51131553A (en) A coating method
JPS51131550A (en) A coating method
JPS51139080A (en) Parking warehouse